Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Snape

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|August 6, 2017
Emerging clinical experience with vaccines against group B meningococcal diseaseA L Wilkins, M D Snape
Clinical and Vaccine Immunology : CVI|November 1, 2011
Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhoodA Khatami, A Peters, H Robinson, et al.
BMJ (Clinical Research Ed.)|June 7, 2008
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyM D Snape, D F Kelly, S Lewis, et al.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
The Journal of Infection|December 3, 2025
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trialE Kelly, M Greenland, P de Whalley, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|August 6, 2017
Emerging clinical experience with vaccines against group B meningococcal diseaseA L Wilkins, M D Snape
Clinical and Vaccine Immunology : CVI|November 1, 2011
Maintenance of immune response throughout childhood following serogroup C meningococcal conjugate vaccination in early childhoodA Khatami, A Peters, H Robinson, et al.
BMJ (Clinical Research Ed.)|June 7, 2008
Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyM D Snape, D F Kelly, S Lewis, et al.
Health Technology Assessment (Winchester, England)|January 20, 2012
A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in childrenP de Whalley, W Walker, M D Snape, et al.
BMJ (Clinical Research Ed.)|May 29, 2010
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyClaire S Waddington, W T Walker, C Oeser, et al.
The Journal of Infection|December 3, 2025
Reactogenicity and immunogenicity following heterologous and homologous third dose COVID-19 vaccination in UK adolescents (Com-COV3): A randomised controlled non-inferiority trialE Kelly, M Greenland, P de Whalley, et al.
Pageof 1